Health Trials

Unrespectable Locally Advanced and or Metastatic HER2 Positive Breast Cancer Participants

1

Review clinical trials related to Unrespectable Locally Advanced and or Metastatic HER2 Positive Breast Cancer Participants. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

JSKN003 Versus Trastuzumab Emtansine (T-DM1) for HER2-Positive, Advanced Breast Cancer

This study is designed to compare the safety and efficacy of JSKN003 versus T-DM1 in unrespectable locally advanced and/or metastatic HER2-positive breast cancer participants previously treated with trastuzumab and taxane.

Participants needed: 228
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Shanghai JMT-Bio Inc.Updated: Mar 24, 2025Locations: 1
Eligibility criteria

1. Voluntarily agree to participate in the study and sign the informed consent. [+11]

1. Have previously been treated with an anti-HER2 ADC loaded with topoisomerase... [+17]

Read more